Nuclear endocrinology in the era of precision medicine
- 1 May 2022
- journal article
- editorial
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 66 (2), 83-85
- https://doi.org/10.23736/s1824-4785.22.03457-4
Abstract
Article: Nuclear endocrinology in the era of precision medicine - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2022 Mar 28 - Minerva Medica - JournalsKeywords
This publication has 8 references indexed in Scilit:
- The EANM practice guidelines for parathyroid imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2021
- European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paragangliomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2019
- Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F–DOPAEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid CancerBioMed Research International, 2016
- Precision Medicine — Personalized, Problematic, and PromisingThe New England Journal of Medicine, 2015
- Role of 18F‐FDOPA PET/CT imaging in endocrinologyClinical Endocrinology, 2014
- Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid CarcinomaClinical Nuclear Medicine, 2012
- Cloning and characterization of the thyroid iodide transporterNature, 1996